Please note: a valid prescription is required for all prescription medication.
Beovu Pre-filled Syringe (brolucizumab)
Get $50 off all orders over $200. Valid on all medications. Use code GET50 at checkout. Offer valid until March 1st.
Coupon code cannot be combined with other offers. Maximum allowable quantity equal to a 90 day supply per single order.Campaign valid for all products, except Mounjaro Vial.
$1,965.99
Secure Encrypted Payments
Beovu Pre-filled Syringe is a single-dose intravitreal medicine (brolucizumab) used by retina specialists for certain retinal conditions. BorderFreeHealth supports access with US shipping from Canada for people paying cash without insurance. This page explains how the drug works, what dosing typically looks like, key safety concerns, and practical handling basics.
This treatment is not self-injected at home. It is prepared and administered in a clinic using sterile technique, with follow-up eye checks that help reduce preventable complications. Information below is meant to support informed discussions with a qualified ophthalmology team and to clarify common logistics for prescription verification and medication handling.
What Beovu Pre-filled Syringe Is and How It Works
Brolucizumab is an anti-VEGF (blood-vessel growth blocker) medicine. It targets vascular endothelial growth factor, a signal involved in abnormal blood vessel growth and fluid leakage in the retina. By reducing this signaling, anti-VEGF therapy can help stabilize vision-related changes associated with wet age-related macular degeneration and similar processes. Ships from Canada to US requires careful coordination because this drug is handled as a refrigerated, clinic-administered injection. Prescriptions are confirmed with the original prescriber before dispensing.
This medicine is given as an intravitreal injection (injection into the eye’s vitreous gel). The injection itself is only one part of treatment; the visit also supports screening for early complications and tracking response over time with retinal imaging. For broader retina-related topics and clinic workflow, browse the Ophthalmology Articles hub.
Who It’s For
This therapy is generally prescribed for adults with neovascular (wet) age-related macular degeneration, a form of macular disease driven by abnormal blood vessels under the retina. Diagnosis and treatment planning are made by an eye specialist based on symptoms, exam findings, and imaging (often OCT scans and angiography). Background reading on the condition and typical care pathways is available in the Neovascular Age Related Macular Degeneration hub.
At a high level, this medicine should not be used in the setting of an active eye or periocular infection, or active intraocular inflammation, because injection can worsen infection or inflammation. A clinician will also review allergy history and prior reactions to similar agents. Additional caution may be needed for people with a history of certain cardiovascular or cerebrovascular events, because anti-VEGF drugs can have systemic effects even when injected into the eye.
Dosage and Usage
Beovu is administered by a trained ophthalmology professional as an intravitreal injection under sterile conditions. Dosing schedules are individualized by the treating retina specialist based on disease activity and follow-up findings. In many labeling schedules, treatment begins with more frequent injections and may later transition to longer intervals if the retina remains stable.
For Beovu Pre-filled Syringe, typical label-based dosing concepts include an initial series of injections about four weeks apart, followed by maintenance dosing at longer intervals (often every 8–12 weeks) when appropriate. Visit timing and monitoring steps can vary by clinic protocol and by the underlying retinal findings.
Why it matters: Clinic-only administration supports sterile technique and timely evaluation of new symptoms.
Strengths and Forms
This product is supplied as a single-dose prefilled syringe intended for intravitreal use. The commonly referenced presentation is brolucizumab 6 mg/0.05 mL (often described as a Beovu 6 mg/0.05 mL prefilled syringe or Beovu 6 mg syringe). Because it is a single-dose device, any remaining solution is discarded after the injection procedure.
The Beovu Pre-filled Syringe format helps standardize preparation by providing a measured volume (0.05 mL) in a ready-to-use presentation, which can reduce certain handling steps compared with multi-dose containers. Availability of specific presentations can vary, and clinic preferences differ. Related ophthalmic prescription products can be browsed in the Ophthalmology Medications collection.
Storage and Travel Basics
This medicine is typically stored refrigerated and protected from light, following the product labeling. It should not be frozen, and it should not be shaken, because rough handling can damage sensitive biologic medicines. Clinics often allow the carton to warm to room temperature before preparation, but exact timing and handling steps should follow the official instructions for the specific lot and market.
For patients traveling to injection appointments, the key practical issue is maintaining appropriate temperature control during transport to the clinic when the medication is shipped to an office location. Beovu Pre-filled Syringe may be shipped using insulated packaging and temperature-monitoring processes suited for refrigerated biologics. For general background on handling guidance language found on prescription cartons, see Doxycycline Capsule Handling, and for an example of why refrigeration details matter for biologics, see Lantus Insulin Guide.
Quick tip: Keep the carton and inserts available for clinic staff on arrival.
Side Effects and Safety
Intravitreal anti-VEGF therapy can cause expected, short-lived effects related to the injection itself, and it also carries rarer but serious risks. Commonly discussed reactions include temporary eye discomfort, redness, small surface bleeding (subconjunctival hemorrhage), floaters, and transient increases in intraocular pressure. Because symptoms can overlap with more serious problems, clinics often provide written warning signs and a clear plan for urgent evaluation.
Serious risks can include endophthalmitis (a serious eye infection), retinal tear or detachment, significant intraocular inflammation, and retinal vasculitis or vascular occlusion, which may threaten vision. Systemic arterial thromboembolic events (such as stroke) are also monitored as a precaution with anti-VEGF agents. Dispensing is handled through licensed Canadian partner pharmacies. For a practical approach to documenting new symptoms and timing, the resource Bupropion Side Effects Guide offers a useful framework that can be adapted to any prescription therapy.
- New severe eye pain: urgent evaluation is needed
- Sudden vision loss: emergency assessment is appropriate
- Increasing redness or discharge: could signal infection
- New flashes or curtain: possible retinal detachment
- Marked light sensitivity: may indicate inflammation
Drug Interactions and Cautions
Because brolucizumab is injected into the eye, classic drug-to-drug interactions seen with oral medicines are less common. Still, the overall treatment plan can be affected by other eye therapies, recent ocular surgery, or concurrent intravitreal injections. Clinicians also consider conditions that raise infection risk or complicate healing, especially when repeated injections are planned.
Caution is often discussed for people with a recent history of certain cardiovascular events and for those who are pregnant or breastfeeding, since systemic exposure, though low, is not zero. A full medication list is still important, including steroid use and immunosuppressive therapies, because they can influence infection and inflammation risk. For a general medication-prep checklist that includes monitoring and red-flag awareness, see Prednisone Practical Safety Prep.
Compare With Alternatives
Retina specialists choose among several anti-VEGF options and related retinal therapies. Differences can involve molecular structure, dosing interval flexibility, clinic workflow, and patient-specific factors seen on imaging. In many practices, the core goal is similar: reduce VEGF-driven leakage and protect the macula while balancing safety and visit burden.
When comparing Beovu Pre-filled Syringe with alternatives, clinicians may discuss agents such as aflibercept and ranibizumab, as well as other retina treatments used in specific scenarios. For reference, BorderFreeHealth also lists Eylea Product Page and Lucentis Prefilled Syringe as separate products; selection depends on the prescriber’s plan and the clinical context.
- Dosing interval options: may vary by label
- Device format: syringe versus vial options
- Monitoring approach: similar safety checks
- Clinic protocol: preparation steps differ
Pricing and Access
Out-of-pocket costs for specialty retina injections can vary based on dispensing channel, required temperature-controlled handling, and the care setting where injections are administered. Some people search for Beovu prefilled syringe cost when comparing cash-pay options or when coverage is limited. Cash-pay access may help when coverage is limited. US delivery from Canada may be part of the fulfillment pathway when the prescription is routed through Canadian partners.
This medicine is available only as Beovu prefilled syringe with prescription, and a clinic address is often used for delivery coordination. BorderFreeHealth facilitates cross-border access through Canadian partner pharmacies, with prescription validation steps built into the process. For site-level updates that may apply to eligible orders, see the Promotions Page. Only one payment approach is not right for everyone, so it can help to review pharmacy documentation requirements and injection visit costs together.
Authoritative Sources
When reviewing any intravitreal anti-VEGF medication, the most reliable details come from official labeling and public health references. These sources outline indicated uses, preparation steps, warnings, and clinician monitoring expectations. If any part of the medication guide conflicts with a clinic’s instructions, the prescriber’s direction and the approved label should take priority.
For primary references, the following sources are commonly used:
- For U.S. labeling context, consult the FDA Drugs@FDA database.
- For Canadian product listings, review the Health Canada Drug Product Database.
- For condition background, see the National Eye Institute AMD overview.
For site checkout, upload the prescription and select prompt, express shipping if offered for the destination.
This content is for informational purposes only and is not a substitute for professional medical advice.
Express Shipping - from $25.00
Shipping with this method takes 3-5 days
Prices:
- Dry-Packed Products $25.00
- Cold-Packed Products $35.00
Shipping Countries:
- United States (all contiguous states**)
- Worldwide (excludes some countries***)
Standard Shipping - $15.00
Shipping with this method takes 5-10 days
Prices:
- Dry-Packed Products $15.00
- Not available for Cold-Packed products
Shipping Countries:
- United States (all contiguous states**)
- Worldwide (excludes some countries***)
What is brolucizumab and what does it do in the eye?
Brolucizumab is an anti-VEGF medicine, meaning it blocks vascular endothelial growth factor, a signal involved in abnormal blood vessel growth and leakage in the retina. In wet age-related macular degeneration, these fragile vessels can leak fluid or bleed, which can affect central vision. By reducing VEGF activity, treatment may help stabilize retinal swelling and related vision changes. The medication is administered as an intravitreal injection by a trained eye-care professional, not used as a self-injection.
How often is Beovu typically injected?
Dosing frequency is determined by the product label and the treating retina specialist’s assessment of disease activity. Many label-based regimens start with an initial series of injections given about four weeks apart. After that, the interval may be extended for some patients, often to every 8–12 weeks, depending on the clinician’s evaluation and imaging findings. Follow-up visits are important even when intervals are extended, because monitoring helps identify early inflammation, pressure changes, or recurrence of retinal fluid.
What symptoms after an intravitreal injection need urgent evaluation?
After any intravitreal injection, certain symptoms are treated as urgent because they can indicate infection, significant inflammation, or retinal detachment. Examples include severe or worsening eye pain, a sudden drop in vision, increasing redness with discharge, new flashes of light, or a curtain-like shadow in vision. While mild irritation or a small red spot on the white of the eye can occur after injections, warning signs should be taken seriously. Clinics usually provide written instructions on what to watch for and whom to contact.
Why do clinics check eye pressure after anti-VEGF injections?
Intraocular pressure can rise temporarily after an intravitreal injection because a small volume of fluid is introduced into the eye. For most people, this increase is short-lived, but monitoring is still important, especially for those with glaucoma or other optic nerve risk factors. Clinics may measure pressure shortly after the injection and at follow-up visits. This check helps identify patients who may need extra observation or pressure-lowering treatment as part of the injection visit protocol.
Who should not receive brolucizumab injections?
High-level contraindications commonly listed for intravitreal anti-VEGF injections include an active ocular or periocular infection and active intraocular inflammation. Using the medication during these situations can worsen infection or inflammation and increase the risk of serious complications. A history of hypersensitivity reactions to the drug or its components is another key reason treatment may be avoided. A retina specialist will review eye exam findings, medical history, and prior injection reactions before proceeding.
What should I ask my retina specialist before starting Beovu?
Useful questions include which diagnosis is being treated, what the planned injection interval is, and how response will be monitored (for example, with OCT imaging). It is also reasonable to ask about the clinic’s safety protocol, including infection prevention steps, eye-pressure monitoring, and what symptoms require urgent evaluation. For people with a history of eye inflammation, glaucoma, or certain cardiovascular events, it can help to discuss how those issues affect risk assessment. Asking about coordination for refrigerated medication handling and appointment timing is also practical.
Rewards Program
Earn points on birthdays, product orders, reviews, friend referrals, and more! Enjoy your medication at unparalleled discounts while reaping rewards for every step you take with us.
You can read more about rewards here.
POINT VALUE
How to earn points
- 1Create an account and start earning.
- 2Earn points every time you shop or perform certain actions.
- 3Redeem points for exclusive discounts.
How to book an appointment
- 1Create Begin by completing a profile or log into your existing account. This step ensures we have the necessary information to provide you with a service that's tailored to your needs. account and start earning.
- 2Scheduling an appointment with our online booking system is easy. Pick a day and time that suits you. You’ll receive an immediate confirmation, without the wait.
- 3Discuss your concerns and symptoms and receive a thorough diagnosis from one of our licensed doctors during a confidential video appointment.
- 4If you've been prescribed medication, your Rx is sent directly to one of our licensed pharmacies and delivered right to your door.
Get Started
To book an online doctor appointment, register for an account or login. After doing so, you can book your visit on this page.

